Sensory Sensitivities

Heightened sensitivity to sensory stimuli is a common but often underrecognized feature of ME/CFS, present in 70–90% of patients (Jason et al. 2013).

1 Types of Sensory Sensitivity

Photophobia (Light Sensitivity). Light sensitivity affects approximately 70% of ME/CFS patients (Jason et al. 2013). Manifestations include:

  • Inability to tolerate bright lights, including sunlight and fluorescent lighting
  • Need for sunglasses indoors or dimmed environments
  • Headaches or symptom exacerbation triggered by light exposure
  • Difficulty with screens (computers, phones, televisions)
  • Preference for dark or low-light environments

Light sensitivity may reflect autonomic dysfunction affecting pupillary control, central sensitization affecting visual processing, or neuroinflammation in visual pathways.

Phonophobia (Sound Sensitivity). Sound sensitivity affects 60–80% of patients and can be severely disabling (Jason et al. 2013):

  • Normal conversation volumes feel uncomfortably loud
  • Sudden or unexpected sounds cause startle responses and symptom flares
  • Multiple simultaneous sounds (e.g., conversations in a restaurant) are intolerable
  • Background noise prevents concentration
  • Need for quiet environments or noise-canceling headphones

In severe cases, patients cannot tolerate any sound and require complete silence, significantly limiting social contact and access to medical care.

Chemical Sensitivity (Multiple Chemical Sensitivity). Sensitivity to chemicals and odors affects 40–60% of ME/CFS patients (Jason et al. 2013):

  • Fragrances (perfumes, cleaning products, air fresheners) trigger symptoms
  • Exhaust fumes and other environmental pollutants cause reactions
  • New materials (carpets, furniture, paint) provoke symptoms
  • Symptoms may include headache, cognitive dysfunction, nausea, respiratory symptoms
  • Overlap with Multiple Chemical Sensitivity (MCS) syndrome

Touch and Pressure Sensitivity. Tactile hypersensitivity manifests as:

  • Allodynia—painful response to normally non-painful touch
  • Clothing tags, seams, or tight clothing feel unbearable
  • Difficulty tolerating physical examination
  • Hyperalgesia—exaggerated pain response to mildly painful stimuli

This overlaps with the central sensitization mechanisms described in the Pain section.

Temperature Sensitivity. Intolerance to temperature extremes affects most patients:

  • Heat intolerance with symptom exacerbation in warm environments
  • Cold intolerance with difficulty warming up
  • Narrow range of comfortable temperatures
  • Symptoms triggered by temperature changes

This reflects autonomic dysfunction affecting thermoregulation (see Section Autonomic Dysfunction).

2 Mechanisms of Sensory Sensitivity

Central Sensitization. The same central sensitization mechanisms that produce pain hypersensitivity likely underlie broader sensory sensitivities. Reduced inhibitory control in the central nervous system leads to amplification of all sensory inputs, not just nociceptive signals (Nijs et al. 2017).

Neuroinflammation. Glial activation and neuroinflammatory processes may directly affect sensory processing pathways, reducing thresholds for activation and impairing habituation to repeated stimuli.

Autonomic Dysfunction. Dysautonomia contributes to sensory sensitivity through impaired pupillary control (photophobia), altered blood flow to sensory organs, and dysfunctional sympathetic responses to stimuli.

Energy Depletion. Sensory processing requires energy. With baseline energy insufficiency, normal sensory processing may exceed available cellular resources, leading to symptoms from stimulation that healthy individuals filter automatically.

TRPM3/PIP2 Calcium Channel Dysfunction. An additional mechanism involves PIP2-dependent ion channel gating. TRPM3, TRPV1, and other calcium-permeable channels require membrane PIP2 for normal gating. When PIP2 is depleted — as proposed in ME/CFS via GPCR autoantibody-driven chronic PLC activation (Lithium Safety: Drug Interactions and Contraindications in Chapter Neurological and Neurocognitive Dysfunction) — TRP channels become unstable, producing noisy spontaneous activity and hyper-responsiveness to sub-threshold stimuli. This mechanism predicts that sensory hypersensitivity is state-dependent (worsening during periods of rapid PIP2 consumption such as PEM crashes) rather than a fixed sensory processing difference. A clinical signal consistent with this prediction comes from a non-ME/CFS case report where episodic sensory hypersensitivity (sound, screens, crowds, eye contact) resolved completely on ultra-low-dose lithium citrate (2 mg/day Li+), a dose expected to modestly reduce PI cycle flux (Sikorav 2026). This is consistent with — but does not establish — the hypothesis that PIP2 gating instability underlies state-dependent sensory hypersensitivity. No ME/CFS-specific data on PIP2/TRP channel function and sensory gating exist.

3 Clinical Implications

Activity Limitation. Sensory sensitivities profoundly limit function:

  • Medical appointments become challenging (bright lights, waiting room noise, chemical smells)
  • Shopping, restaurants, and public spaces are often intolerable
  • Work environments may be impossible to tolerate
  • Social gatherings exceed sensory capacity

Assessment Considerations. When evaluating ME/CFS patients, clinicians should:

  • Ask specifically about sensory sensitivities
  • Modify examination environments (dim lights, reduce noise)
  • Allow patients to wear sunglasses or earplugs
  • Avoid fragranced products
  • Recognize that sensory overload can trigger PEM

Management. Management focuses on environmental modification:

  • Sunglasses, tinted lenses, or FL-41 lenses for photophobia
  • Noise-canceling headphones or earplugs for phonophobia
  • Fragrance-free environments and products
  • Loose, soft clothing without tags or seams
  • Temperature-controlled environments with ability to layer clothing
  • Gradual, controlled exposure when improvement occurs

References

Jason, Leonard A, Mary Brown, Meredyth Evans, Madison Sunnquist, and Julia L Newton. 2013. “Contrasting Chronic Fatigue Syndrome Versus Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.” Fatigue: Biomedicine, Health & Behavior 1 (3): 168–83. https://doi.org/10.1080/21641846.2013.774556.
Nijs, Jo, Marco L Loggia, Andrea Polli, Maarten Moens, Eva Huysmans, Lisa Goudman, Mira Meeus, Luc Vanderweeën, Kelly Ickmans, and Daniel J Clauw. 2017. “Sleep Disturbances and Severe Stress as Glial Activators: Key Targets for Treating Central Sensitization in Chronic Pain Patients?” Expert Opinion on Therapeutic Targets 21 (8): 817–26. https://doi.org/10.1080/14728222.2017.1353603.
Sikorav, Michael. 2026. “Ultra-Low-Dose Lithium Citrate for Recurrent Brief Depressive Episodes with Sensory Hypersensitivity: A Self-Experiment Case Report.” Psychiatrie Internationale (independent journal). June 2026.